跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
ALZIL PLUS 40 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
ALZIL PLUS 40 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Ferrer Internacional S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 6, 2020
Approval ID
a6384f96cdcb1301
Company
Ferrer Internacional S.A.
Type
Standard
Approval Details
Approval Id
a6384f96cdcb1301
Drug Cima Aemps Name
ALZIL PLUS 40 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
85378
Holder Company Name
Ferrer Internacional S.A.
Marketing Company Name
Ferrer Internacional S.A.
Holder Company Detail Path
/organization/ferrer-internacional-s-a
Marketing Company Detail Path
/organization/ferrer-internacional-s-a
Authorization Date
2020-09-06
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
40 mg/10 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Ferrer Internacional S.A.
Company Detail Path
/organization/ferrer-internacional-s-a
Company Information
Pharmaceutical Company Name
Ferrer Internacional S.A.
Country Name
Chile
City Name
santiago,santiago,country_cl
Address
Av Quilin 5273
Active Ingredients
ROSUVASTATINA CALCICA
41,6 mg
EZETIMIBA
10 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 6, 2020
Approval ID
a6384f96cdcb1301
Type
Standard
Back to CIMA-AEMPS Approvals
ALZIL PLUS 40 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details